Global Donepezil Market

Donepezil Comprehensive Study by Type (5mg, 10mg, 23mg), Application (Hospitals, Clinics, Drugstore), Distribution Channel (Online, Offline) Players and Region - Global Market Outlook to 2027

Donepezil Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Industry Background:
Donepezil is also called as Aricept. Donepezil is a medication that used to treatment of Alzheimer's disease. It is available in 5mg, 10mg and 23mg. Donepezil was approved for medical use in the United States in 1996. It is available online as well as offline. Rising prevalence of Alzheimer’s disease and increasing geriatric population worldwide will help to boost the global Donepezil market.This growth is primarily driven by Rising Prevalence of Alzheimer's disease and Increasing Geriatric Population Worldwide.

Globally, a noticeable market trend is evident Rapid Development in Medication-Related to Alzheimer’s Disease. Major Players, such as Eisai (Japan), Pfizer (United States), Teva (Israel), Sandoz (Germany), Apotex (Canada), Dr Reddy's Laboratories (India), Sun Pharmaceutical (India), Hansoh Pharma (China) and Cipla (India) etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.

Market Drivers
  • Rising Prevalence of Alzheimer's disease
  • Increasing Geriatric Population Worldwide

Market Trend
  • Rapid Development in Medication-Related to Alzheimer’s Disease

Restraints
  • Side Effects and Infections of Drugs
  • Lack of Awareness

Opportunities
Growing Healthcare Expenditure in Developed Countries
Challenges
Availability of Alternatives Drugs

AMA Research follow a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcase the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyse the products and services offered by multiple players competing to increase their market share and presence.

Customization in the Report
AMA Research features not only specific market forecasts, but also include significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints
- New Entrants into the Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis

Against this Challenging Backdrop, Donepezil Study Sheds Light on
— The Donepezil Market status quo and key characteristics. To end this, Analyst at AMA organize and took survey of the Donepezil industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
— Where Donepezil industry is heading and what are the top priorities. Insights are drawn from financial analysis, the survey and interviews with key executives and industry experts.
— How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold value they currently claim, or capture the new addressable opportunity.

Report Objectives / Segmentation Covered

By Type
  • 5mg
  • 10mg
  • 23mg
By Application
  • Hospitals
  • Clinics
  • Drugstore
By Distribution Channel
  • Online
  • Offline

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rising Prevalence of Alzheimer's disease
      • 3.2.2. Increasing Geriatric Population Worldwide
    • 3.3. Market Challenges
      • 3.3.1. Availability of Alternatives Drugs
    • 3.4. Market Trends
      • 3.4.1. Rapid Development in Medication-Related to Alzheimer’s Disease
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Donepezil, by Type, Application, Distribution Channel and Region (value, volume and price ) (2016-2021)
    • 5.1. Introduction
    • 5.2. Global Donepezil (Value)
      • 5.2.1. Global Donepezil by: Type (Value)
        • 5.2.1.1. 5mg
        • 5.2.1.2. 10mg
        • 5.2.1.3. 23mg
      • 5.2.2. Global Donepezil by: Application (Value)
        • 5.2.2.1. Hospitals
        • 5.2.2.2. Clinics
        • 5.2.2.3. Drugstore
      • 5.2.3. Global Donepezil by: Distribution Channel (Value)
        • 5.2.3.1. Online
        • 5.2.3.2. Offline
      • 5.2.4. Global Donepezil Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Donepezil (Volume)
      • 5.3.1. Global Donepezil by: Type (Volume)
        • 5.3.1.1. 5mg
        • 5.3.1.2. 10mg
        • 5.3.1.3. 23mg
      • 5.3.2. Global Donepezil by: Application (Volume)
        • 5.3.2.1. Hospitals
        • 5.3.2.2. Clinics
        • 5.3.2.3. Drugstore
      • 5.3.3. Global Donepezil by: Distribution Channel (Volume)
        • 5.3.3.1. Online
        • 5.3.3.2. Offline
      • 5.3.4. Global Donepezil Region
        • 5.3.4.1. South America
          • 5.3.4.1.1. Brazil
          • 5.3.4.1.2. Argentina
          • 5.3.4.1.3. Rest of South America
        • 5.3.4.2. Asia Pacific
          • 5.3.4.2.1. China
          • 5.3.4.2.2. Japan
          • 5.3.4.2.3. India
          • 5.3.4.2.4. South Korea
          • 5.3.4.2.5. Taiwan
          • 5.3.4.2.6. Australia
          • 5.3.4.2.7. Rest of Asia-Pacific
        • 5.3.4.3. Europe
          • 5.3.4.3.1. Germany
          • 5.3.4.3.2. France
          • 5.3.4.3.3. Italy
          • 5.3.4.3.4. United Kingdom
          • 5.3.4.3.5. Netherlands
          • 5.3.4.3.6. Rest of Europe
        • 5.3.4.4. MEA
          • 5.3.4.4.1. Middle East
          • 5.3.4.4.2. Africa
        • 5.3.4.5. North America
          • 5.3.4.5.1. United States
          • 5.3.4.5.2. Canada
          • 5.3.4.5.3. Mexico
    • 5.4. Global Donepezil (Price)
      • 5.4.1. Global Donepezil by: Type (Price)
  • 6. Donepezil: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2021)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Eisai (Japan)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Pfizer (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Teva (Israel)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Sandoz (Germany)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Apotex (Canada)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Dr Reddy's Laboratories (India)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Sun Pharmaceutical (India)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Hansoh Pharma (China)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Cipla (India)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
  • 7. Global Donepezil Sale, by Type, Application, Distribution Channel and Region (value, volume and price ) (2022-2027)
    • 7.1. Introduction
    • 7.2. Global Donepezil (Value)
      • 7.2.1. Global Donepezil by: Type (Value)
        • 7.2.1.1. 5mg
        • 7.2.1.2. 10mg
        • 7.2.1.3. 23mg
      • 7.2.2. Global Donepezil by: Application (Value)
        • 7.2.2.1. Hospitals
        • 7.2.2.2. Clinics
        • 7.2.2.3. Drugstore
      • 7.2.3. Global Donepezil by: Distribution Channel (Value)
        • 7.2.3.1. Online
        • 7.2.3.2. Offline
      • 7.2.4. Global Donepezil Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Donepezil (Volume)
      • 7.3.1. Global Donepezil by: Type (Volume)
        • 7.3.1.1. 5mg
        • 7.3.1.2. 10mg
        • 7.3.1.3. 23mg
      • 7.3.2. Global Donepezil by: Application (Volume)
        • 7.3.2.1. Hospitals
        • 7.3.2.2. Clinics
        • 7.3.2.3. Drugstore
      • 7.3.3. Global Donepezil by: Distribution Channel (Volume)
        • 7.3.3.1. Online
        • 7.3.3.2. Offline
      • 7.3.4. Global Donepezil Region
        • 7.3.4.1. South America
          • 7.3.4.1.1. Brazil
          • 7.3.4.1.2. Argentina
          • 7.3.4.1.3. Rest of South America
        • 7.3.4.2. Asia Pacific
          • 7.3.4.2.1. China
          • 7.3.4.2.2. Japan
          • 7.3.4.2.3. India
          • 7.3.4.2.4. South Korea
          • 7.3.4.2.5. Taiwan
          • 7.3.4.2.6. Australia
          • 7.3.4.2.7. Rest of Asia-Pacific
        • 7.3.4.3. Europe
          • 7.3.4.3.1. Germany
          • 7.3.4.3.2. France
          • 7.3.4.3.3. Italy
          • 7.3.4.3.4. United Kingdom
          • 7.3.4.3.5. Netherlands
          • 7.3.4.3.6. Rest of Europe
        • 7.3.4.4. MEA
          • 7.3.4.4.1. Middle East
          • 7.3.4.4.2. Africa
        • 7.3.4.5. North America
          • 7.3.4.5.1. United States
          • 7.3.4.5.2. Canada
          • 7.3.4.5.3. Mexico
    • 7.4. Global Donepezil (Price)
      • 7.4.1. Global Donepezil by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Donepezil: by Type(USD Million)
  • Table 2. Donepezil 5mg , by Region USD Million (2016-2021)
  • Table 3. Donepezil 10mg , by Region USD Million (2016-2021)
  • Table 4. Donepezil 23mg , by Region USD Million (2016-2021)
  • Table 5. Donepezil: by Application(USD Million)
  • Table 6. Donepezil Hospitals , by Region USD Million (2016-2021)
  • Table 7. Donepezil Clinics , by Region USD Million (2016-2021)
  • Table 8. Donepezil Drugstore , by Region USD Million (2016-2021)
  • Table 9. Donepezil: by Distribution Channel(USD Million)
  • Table 10. Donepezil Online , by Region USD Million (2016-2021)
  • Table 11. Donepezil Offline , by Region USD Million (2016-2021)
  • Table 12. South America Donepezil, by Country USD Million (2016-2021)
  • Table 13. South America Donepezil, by Type USD Million (2016-2021)
  • Table 14. South America Donepezil, by Application USD Million (2016-2021)
  • Table 15. South America Donepezil, by Distribution Channel USD Million (2016-2021)
  • Table 16. Brazil Donepezil, by Type USD Million (2016-2021)
  • Table 17. Brazil Donepezil, by Application USD Million (2016-2021)
  • Table 18. Brazil Donepezil, by Distribution Channel USD Million (2016-2021)
  • Table 19. Argentina Donepezil, by Type USD Million (2016-2021)
  • Table 20. Argentina Donepezil, by Application USD Million (2016-2021)
  • Table 21. Argentina Donepezil, by Distribution Channel USD Million (2016-2021)
  • Table 22. Rest of South America Donepezil, by Type USD Million (2016-2021)
  • Table 23. Rest of South America Donepezil, by Application USD Million (2016-2021)
  • Table 24. Rest of South America Donepezil, by Distribution Channel USD Million (2016-2021)
  • Table 25. Asia Pacific Donepezil, by Country USD Million (2016-2021)
  • Table 26. Asia Pacific Donepezil, by Type USD Million (2016-2021)
  • Table 27. Asia Pacific Donepezil, by Application USD Million (2016-2021)
  • Table 28. Asia Pacific Donepezil, by Distribution Channel USD Million (2016-2021)
  • Table 29. China Donepezil, by Type USD Million (2016-2021)
  • Table 30. China Donepezil, by Application USD Million (2016-2021)
  • Table 31. China Donepezil, by Distribution Channel USD Million (2016-2021)
  • Table 32. Japan Donepezil, by Type USD Million (2016-2021)
  • Table 33. Japan Donepezil, by Application USD Million (2016-2021)
  • Table 34. Japan Donepezil, by Distribution Channel USD Million (2016-2021)
  • Table 35. India Donepezil, by Type USD Million (2016-2021)
  • Table 36. India Donepezil, by Application USD Million (2016-2021)
  • Table 37. India Donepezil, by Distribution Channel USD Million (2016-2021)
  • Table 38. South Korea Donepezil, by Type USD Million (2016-2021)
  • Table 39. South Korea Donepezil, by Application USD Million (2016-2021)
  • Table 40. South Korea Donepezil, by Distribution Channel USD Million (2016-2021)
  • Table 41. Taiwan Donepezil, by Type USD Million (2016-2021)
  • Table 42. Taiwan Donepezil, by Application USD Million (2016-2021)
  • Table 43. Taiwan Donepezil, by Distribution Channel USD Million (2016-2021)
  • Table 44. Australia Donepezil, by Type USD Million (2016-2021)
  • Table 45. Australia Donepezil, by Application USD Million (2016-2021)
  • Table 46. Australia Donepezil, by Distribution Channel USD Million (2016-2021)
  • Table 47. Rest of Asia-Pacific Donepezil, by Type USD Million (2016-2021)
  • Table 48. Rest of Asia-Pacific Donepezil, by Application USD Million (2016-2021)
  • Table 49. Rest of Asia-Pacific Donepezil, by Distribution Channel USD Million (2016-2021)
  • Table 50. Europe Donepezil, by Country USD Million (2016-2021)
  • Table 51. Europe Donepezil, by Type USD Million (2016-2021)
  • Table 52. Europe Donepezil, by Application USD Million (2016-2021)
  • Table 53. Europe Donepezil, by Distribution Channel USD Million (2016-2021)
  • Table 54. Germany Donepezil, by Type USD Million (2016-2021)
  • Table 55. Germany Donepezil, by Application USD Million (2016-2021)
  • Table 56. Germany Donepezil, by Distribution Channel USD Million (2016-2021)
  • Table 57. France Donepezil, by Type USD Million (2016-2021)
  • Table 58. France Donepezil, by Application USD Million (2016-2021)
  • Table 59. France Donepezil, by Distribution Channel USD Million (2016-2021)
  • Table 60. Italy Donepezil, by Type USD Million (2016-2021)
  • Table 61. Italy Donepezil, by Application USD Million (2016-2021)
  • Table 62. Italy Donepezil, by Distribution Channel USD Million (2016-2021)
  • Table 63. United Kingdom Donepezil, by Type USD Million (2016-2021)
  • Table 64. United Kingdom Donepezil, by Application USD Million (2016-2021)
  • Table 65. United Kingdom Donepezil, by Distribution Channel USD Million (2016-2021)
  • Table 66. Netherlands Donepezil, by Type USD Million (2016-2021)
  • Table 67. Netherlands Donepezil, by Application USD Million (2016-2021)
  • Table 68. Netherlands Donepezil, by Distribution Channel USD Million (2016-2021)
  • Table 69. Rest of Europe Donepezil, by Type USD Million (2016-2021)
  • Table 70. Rest of Europe Donepezil, by Application USD Million (2016-2021)
  • Table 71. Rest of Europe Donepezil, by Distribution Channel USD Million (2016-2021)
  • Table 72. MEA Donepezil, by Country USD Million (2016-2021)
  • Table 73. MEA Donepezil, by Type USD Million (2016-2021)
  • Table 74. MEA Donepezil, by Application USD Million (2016-2021)
  • Table 75. MEA Donepezil, by Distribution Channel USD Million (2016-2021)
  • Table 76. Middle East Donepezil, by Type USD Million (2016-2021)
  • Table 77. Middle East Donepezil, by Application USD Million (2016-2021)
  • Table 78. Middle East Donepezil, by Distribution Channel USD Million (2016-2021)
  • Table 79. Africa Donepezil, by Type USD Million (2016-2021)
  • Table 80. Africa Donepezil, by Application USD Million (2016-2021)
  • Table 81. Africa Donepezil, by Distribution Channel USD Million (2016-2021)
  • Table 82. North America Donepezil, by Country USD Million (2016-2021)
  • Table 83. North America Donepezil, by Type USD Million (2016-2021)
  • Table 84. North America Donepezil, by Application USD Million (2016-2021)
  • Table 85. North America Donepezil, by Distribution Channel USD Million (2016-2021)
  • Table 86. United States Donepezil, by Type USD Million (2016-2021)
  • Table 87. United States Donepezil, by Application USD Million (2016-2021)
  • Table 88. United States Donepezil, by Distribution Channel USD Million (2016-2021)
  • Table 89. Canada Donepezil, by Type USD Million (2016-2021)
  • Table 90. Canada Donepezil, by Application USD Million (2016-2021)
  • Table 91. Canada Donepezil, by Distribution Channel USD Million (2016-2021)
  • Table 92. Mexico Donepezil, by Type USD Million (2016-2021)
  • Table 93. Mexico Donepezil, by Application USD Million (2016-2021)
  • Table 94. Mexico Donepezil, by Distribution Channel USD Million (2016-2021)
  • Table 95. Donepezil Sales: by Type(K Units)
  • Table 96. Donepezil Sales 5mg , by Region K Units (2016-2021)
  • Table 97. Donepezil Sales 10mg , by Region K Units (2016-2021)
  • Table 98. Donepezil Sales 23mg , by Region K Units (2016-2021)
  • Table 99. Donepezil Sales: by Application(K Units)
  • Table 100. Donepezil Sales Hospitals , by Region K Units (2016-2021)
  • Table 101. Donepezil Sales Clinics , by Region K Units (2016-2021)
  • Table 102. Donepezil Sales Drugstore , by Region K Units (2016-2021)
  • Table 103. Donepezil Sales: by Distribution Channel(K Units)
  • Table 104. Donepezil Sales Online , by Region K Units (2016-2021)
  • Table 105. Donepezil Sales Offline , by Region K Units (2016-2021)
  • Table 106. South America Donepezil Sales, by Country K Units (2016-2021)
  • Table 107. South America Donepezil Sales, by Type K Units (2016-2021)
  • Table 108. South America Donepezil Sales, by Application K Units (2016-2021)
  • Table 109. South America Donepezil Sales, by Distribution Channel K Units (2016-2021)
  • Table 110. Brazil Donepezil Sales, by Type K Units (2016-2021)
  • Table 111. Brazil Donepezil Sales, by Application K Units (2016-2021)
  • Table 112. Brazil Donepezil Sales, by Distribution Channel K Units (2016-2021)
  • Table 113. Argentina Donepezil Sales, by Type K Units (2016-2021)
  • Table 114. Argentina Donepezil Sales, by Application K Units (2016-2021)
  • Table 115. Argentina Donepezil Sales, by Distribution Channel K Units (2016-2021)
  • Table 116. Rest of South America Donepezil Sales, by Type K Units (2016-2021)
  • Table 117. Rest of South America Donepezil Sales, by Application K Units (2016-2021)
  • Table 118. Rest of South America Donepezil Sales, by Distribution Channel K Units (2016-2021)
  • Table 119. Asia Pacific Donepezil Sales, by Country K Units (2016-2021)
  • Table 120. Asia Pacific Donepezil Sales, by Type K Units (2016-2021)
  • Table 121. Asia Pacific Donepezil Sales, by Application K Units (2016-2021)
  • Table 122. Asia Pacific Donepezil Sales, by Distribution Channel K Units (2016-2021)
  • Table 123. China Donepezil Sales, by Type K Units (2016-2021)
  • Table 124. China Donepezil Sales, by Application K Units (2016-2021)
  • Table 125. China Donepezil Sales, by Distribution Channel K Units (2016-2021)
  • Table 126. Japan Donepezil Sales, by Type K Units (2016-2021)
  • Table 127. Japan Donepezil Sales, by Application K Units (2016-2021)
  • Table 128. Japan Donepezil Sales, by Distribution Channel K Units (2016-2021)
  • Table 129. India Donepezil Sales, by Type K Units (2016-2021)
  • Table 130. India Donepezil Sales, by Application K Units (2016-2021)
  • Table 131. India Donepezil Sales, by Distribution Channel K Units (2016-2021)
  • Table 132. South Korea Donepezil Sales, by Type K Units (2016-2021)
  • Table 133. South Korea Donepezil Sales, by Application K Units (2016-2021)
  • Table 134. South Korea Donepezil Sales, by Distribution Channel K Units (2016-2021)
  • Table 135. Taiwan Donepezil Sales, by Type K Units (2016-2021)
  • Table 136. Taiwan Donepezil Sales, by Application K Units (2016-2021)
  • Table 137. Taiwan Donepezil Sales, by Distribution Channel K Units (2016-2021)
  • Table 138. Australia Donepezil Sales, by Type K Units (2016-2021)
  • Table 139. Australia Donepezil Sales, by Application K Units (2016-2021)
  • Table 140. Australia Donepezil Sales, by Distribution Channel K Units (2016-2021)
  • Table 141. Rest of Asia-Pacific Donepezil Sales, by Type K Units (2016-2021)
  • Table 142. Rest of Asia-Pacific Donepezil Sales, by Application K Units (2016-2021)
  • Table 143. Rest of Asia-Pacific Donepezil Sales, by Distribution Channel K Units (2016-2021)
  • Table 144. Europe Donepezil Sales, by Country K Units (2016-2021)
  • Table 145. Europe Donepezil Sales, by Type K Units (2016-2021)
  • Table 146. Europe Donepezil Sales, by Application K Units (2016-2021)
  • Table 147. Europe Donepezil Sales, by Distribution Channel K Units (2016-2021)
  • Table 148. Germany Donepezil Sales, by Type K Units (2016-2021)
  • Table 149. Germany Donepezil Sales, by Application K Units (2016-2021)
  • Table 150. Germany Donepezil Sales, by Distribution Channel K Units (2016-2021)
  • Table 151. France Donepezil Sales, by Type K Units (2016-2021)
  • Table 152. France Donepezil Sales, by Application K Units (2016-2021)
  • Table 153. France Donepezil Sales, by Distribution Channel K Units (2016-2021)
  • Table 154. Italy Donepezil Sales, by Type K Units (2016-2021)
  • Table 155. Italy Donepezil Sales, by Application K Units (2016-2021)
  • Table 156. Italy Donepezil Sales, by Distribution Channel K Units (2016-2021)
  • Table 157. United Kingdom Donepezil Sales, by Type K Units (2016-2021)
  • Table 158. United Kingdom Donepezil Sales, by Application K Units (2016-2021)
  • Table 159. United Kingdom Donepezil Sales, by Distribution Channel K Units (2016-2021)
  • Table 160. Netherlands Donepezil Sales, by Type K Units (2016-2021)
  • Table 161. Netherlands Donepezil Sales, by Application K Units (2016-2021)
  • Table 162. Netherlands Donepezil Sales, by Distribution Channel K Units (2016-2021)
  • Table 163. Rest of Europe Donepezil Sales, by Type K Units (2016-2021)
  • Table 164. Rest of Europe Donepezil Sales, by Application K Units (2016-2021)
  • Table 165. Rest of Europe Donepezil Sales, by Distribution Channel K Units (2016-2021)
  • Table 166. MEA Donepezil Sales, by Country K Units (2016-2021)
  • Table 167. MEA Donepezil Sales, by Type K Units (2016-2021)
  • Table 168. MEA Donepezil Sales, by Application K Units (2016-2021)
  • Table 169. MEA Donepezil Sales, by Distribution Channel K Units (2016-2021)
  • Table 170. Middle East Donepezil Sales, by Type K Units (2016-2021)
  • Table 171. Middle East Donepezil Sales, by Application K Units (2016-2021)
  • Table 172. Middle East Donepezil Sales, by Distribution Channel K Units (2016-2021)
  • Table 173. Africa Donepezil Sales, by Type K Units (2016-2021)
  • Table 174. Africa Donepezil Sales, by Application K Units (2016-2021)
  • Table 175. Africa Donepezil Sales, by Distribution Channel K Units (2016-2021)
  • Table 176. North America Donepezil Sales, by Country K Units (2016-2021)
  • Table 177. North America Donepezil Sales, by Type K Units (2016-2021)
  • Table 178. North America Donepezil Sales, by Application K Units (2016-2021)
  • Table 179. North America Donepezil Sales, by Distribution Channel K Units (2016-2021)
  • Table 180. United States Donepezil Sales, by Type K Units (2016-2021)
  • Table 181. United States Donepezil Sales, by Application K Units (2016-2021)
  • Table 182. United States Donepezil Sales, by Distribution Channel K Units (2016-2021)
  • Table 183. Canada Donepezil Sales, by Type K Units (2016-2021)
  • Table 184. Canada Donepezil Sales, by Application K Units (2016-2021)
  • Table 185. Canada Donepezil Sales, by Distribution Channel K Units (2016-2021)
  • Table 186. Mexico Donepezil Sales, by Type K Units (2016-2021)
  • Table 187. Mexico Donepezil Sales, by Application K Units (2016-2021)
  • Table 188. Mexico Donepezil Sales, by Distribution Channel K Units (2016-2021)
  • Table 189. Donepezil: by Type(USD/Units)
  • Table 190. Company Basic Information, Sales Area and Its Competitors
  • Table 191. Company Basic Information, Sales Area and Its Competitors
  • Table 192. Company Basic Information, Sales Area and Its Competitors
  • Table 193. Company Basic Information, Sales Area and Its Competitors
  • Table 194. Company Basic Information, Sales Area and Its Competitors
  • Table 195. Company Basic Information, Sales Area and Its Competitors
  • Table 196. Company Basic Information, Sales Area and Its Competitors
  • Table 197. Company Basic Information, Sales Area and Its Competitors
  • Table 198. Company Basic Information, Sales Area and Its Competitors
  • Table 199. Donepezil: by Type(USD Million)
  • Table 200. Donepezil 5mg , by Region USD Million (2022-2027)
  • Table 201. Donepezil 10mg , by Region USD Million (2022-2027)
  • Table 202. Donepezil 23mg , by Region USD Million (2022-2027)
  • Table 203. Donepezil: by Application(USD Million)
  • Table 204. Donepezil Hospitals , by Region USD Million (2022-2027)
  • Table 205. Donepezil Clinics , by Region USD Million (2022-2027)
  • Table 206. Donepezil Drugstore , by Region USD Million (2022-2027)
  • Table 207. Donepezil: by Distribution Channel(USD Million)
  • Table 208. Donepezil Online , by Region USD Million (2022-2027)
  • Table 209. Donepezil Offline , by Region USD Million (2022-2027)
  • Table 210. South America Donepezil, by Country USD Million (2022-2027)
  • Table 211. South America Donepezil, by Type USD Million (2022-2027)
  • Table 212. South America Donepezil, by Application USD Million (2022-2027)
  • Table 213. South America Donepezil, by Distribution Channel USD Million (2022-2027)
  • Table 214. Brazil Donepezil, by Type USD Million (2022-2027)
  • Table 215. Brazil Donepezil, by Application USD Million (2022-2027)
  • Table 216. Brazil Donepezil, by Distribution Channel USD Million (2022-2027)
  • Table 217. Argentina Donepezil, by Type USD Million (2022-2027)
  • Table 218. Argentina Donepezil, by Application USD Million (2022-2027)
  • Table 219. Argentina Donepezil, by Distribution Channel USD Million (2022-2027)
  • Table 220. Rest of South America Donepezil, by Type USD Million (2022-2027)
  • Table 221. Rest of South America Donepezil, by Application USD Million (2022-2027)
  • Table 222. Rest of South America Donepezil, by Distribution Channel USD Million (2022-2027)
  • Table 223. Asia Pacific Donepezil, by Country USD Million (2022-2027)
  • Table 224. Asia Pacific Donepezil, by Type USD Million (2022-2027)
  • Table 225. Asia Pacific Donepezil, by Application USD Million (2022-2027)
  • Table 226. Asia Pacific Donepezil, by Distribution Channel USD Million (2022-2027)
  • Table 227. China Donepezil, by Type USD Million (2022-2027)
  • Table 228. China Donepezil, by Application USD Million (2022-2027)
  • Table 229. China Donepezil, by Distribution Channel USD Million (2022-2027)
  • Table 230. Japan Donepezil, by Type USD Million (2022-2027)
  • Table 231. Japan Donepezil, by Application USD Million (2022-2027)
  • Table 232. Japan Donepezil, by Distribution Channel USD Million (2022-2027)
  • Table 233. India Donepezil, by Type USD Million (2022-2027)
  • Table 234. India Donepezil, by Application USD Million (2022-2027)
  • Table 235. India Donepezil, by Distribution Channel USD Million (2022-2027)
  • Table 236. South Korea Donepezil, by Type USD Million (2022-2027)
  • Table 237. South Korea Donepezil, by Application USD Million (2022-2027)
  • Table 238. South Korea Donepezil, by Distribution Channel USD Million (2022-2027)
  • Table 239. Taiwan Donepezil, by Type USD Million (2022-2027)
  • Table 240. Taiwan Donepezil, by Application USD Million (2022-2027)
  • Table 241. Taiwan Donepezil, by Distribution Channel USD Million (2022-2027)
  • Table 242. Australia Donepezil, by Type USD Million (2022-2027)
  • Table 243. Australia Donepezil, by Application USD Million (2022-2027)
  • Table 244. Australia Donepezil, by Distribution Channel USD Million (2022-2027)
  • Table 245. Rest of Asia-Pacific Donepezil, by Type USD Million (2022-2027)
  • Table 246. Rest of Asia-Pacific Donepezil, by Application USD Million (2022-2027)
  • Table 247. Rest of Asia-Pacific Donepezil, by Distribution Channel USD Million (2022-2027)
  • Table 248. Europe Donepezil, by Country USD Million (2022-2027)
  • Table 249. Europe Donepezil, by Type USD Million (2022-2027)
  • Table 250. Europe Donepezil, by Application USD Million (2022-2027)
  • Table 251. Europe Donepezil, by Distribution Channel USD Million (2022-2027)
  • Table 252. Germany Donepezil, by Type USD Million (2022-2027)
  • Table 253. Germany Donepezil, by Application USD Million (2022-2027)
  • Table 254. Germany Donepezil, by Distribution Channel USD Million (2022-2027)
  • Table 255. France Donepezil, by Type USD Million (2022-2027)
  • Table 256. France Donepezil, by Application USD Million (2022-2027)
  • Table 257. France Donepezil, by Distribution Channel USD Million (2022-2027)
  • Table 258. Italy Donepezil, by Type USD Million (2022-2027)
  • Table 259. Italy Donepezil, by Application USD Million (2022-2027)
  • Table 260. Italy Donepezil, by Distribution Channel USD Million (2022-2027)
  • Table 261. United Kingdom Donepezil, by Type USD Million (2022-2027)
  • Table 262. United Kingdom Donepezil, by Application USD Million (2022-2027)
  • Table 263. United Kingdom Donepezil, by Distribution Channel USD Million (2022-2027)
  • Table 264. Netherlands Donepezil, by Type USD Million (2022-2027)
  • Table 265. Netherlands Donepezil, by Application USD Million (2022-2027)
  • Table 266. Netherlands Donepezil, by Distribution Channel USD Million (2022-2027)
  • Table 267. Rest of Europe Donepezil, by Type USD Million (2022-2027)
  • Table 268. Rest of Europe Donepezil, by Application USD Million (2022-2027)
  • Table 269. Rest of Europe Donepezil, by Distribution Channel USD Million (2022-2027)
  • Table 270. MEA Donepezil, by Country USD Million (2022-2027)
  • Table 271. MEA Donepezil, by Type USD Million (2022-2027)
  • Table 272. MEA Donepezil, by Application USD Million (2022-2027)
  • Table 273. MEA Donepezil, by Distribution Channel USD Million (2022-2027)
  • Table 274. Middle East Donepezil, by Type USD Million (2022-2027)
  • Table 275. Middle East Donepezil, by Application USD Million (2022-2027)
  • Table 276. Middle East Donepezil, by Distribution Channel USD Million (2022-2027)
  • Table 277. Africa Donepezil, by Type USD Million (2022-2027)
  • Table 278. Africa Donepezil, by Application USD Million (2022-2027)
  • Table 279. Africa Donepezil, by Distribution Channel USD Million (2022-2027)
  • Table 280. North America Donepezil, by Country USD Million (2022-2027)
  • Table 281. North America Donepezil, by Type USD Million (2022-2027)
  • Table 282. North America Donepezil, by Application USD Million (2022-2027)
  • Table 283. North America Donepezil, by Distribution Channel USD Million (2022-2027)
  • Table 284. United States Donepezil, by Type USD Million (2022-2027)
  • Table 285. United States Donepezil, by Application USD Million (2022-2027)
  • Table 286. United States Donepezil, by Distribution Channel USD Million (2022-2027)
  • Table 287. Canada Donepezil, by Type USD Million (2022-2027)
  • Table 288. Canada Donepezil, by Application USD Million (2022-2027)
  • Table 289. Canada Donepezil, by Distribution Channel USD Million (2022-2027)
  • Table 290. Mexico Donepezil, by Type USD Million (2022-2027)
  • Table 291. Mexico Donepezil, by Application USD Million (2022-2027)
  • Table 292. Mexico Donepezil, by Distribution Channel USD Million (2022-2027)
  • Table 293. Donepezil Sales: by Type(K Units)
  • Table 294. Donepezil Sales 5mg , by Region K Units (2022-2027)
  • Table 295. Donepezil Sales 10mg , by Region K Units (2022-2027)
  • Table 296. Donepezil Sales 23mg , by Region K Units (2022-2027)
  • Table 297. Donepezil Sales: by Application(K Units)
  • Table 298. Donepezil Sales Hospitals , by Region K Units (2022-2027)
  • Table 299. Donepezil Sales Clinics , by Region K Units (2022-2027)
  • Table 300. Donepezil Sales Drugstore , by Region K Units (2022-2027)
  • Table 301. Donepezil Sales: by Distribution Channel(K Units)
  • Table 302. Donepezil Sales Online , by Region K Units (2022-2027)
  • Table 303. Donepezil Sales Offline , by Region K Units (2022-2027)
  • Table 304. South America Donepezil Sales, by Country K Units (2022-2027)
  • Table 305. South America Donepezil Sales, by Type K Units (2022-2027)
  • Table 306. South America Donepezil Sales, by Application K Units (2022-2027)
  • Table 307. South America Donepezil Sales, by Distribution Channel K Units (2022-2027)
  • Table 308. Brazil Donepezil Sales, by Type K Units (2022-2027)
  • Table 309. Brazil Donepezil Sales, by Application K Units (2022-2027)
  • Table 310. Brazil Donepezil Sales, by Distribution Channel K Units (2022-2027)
  • Table 311. Argentina Donepezil Sales, by Type K Units (2022-2027)
  • Table 312. Argentina Donepezil Sales, by Application K Units (2022-2027)
  • Table 313. Argentina Donepezil Sales, by Distribution Channel K Units (2022-2027)
  • Table 314. Rest of South America Donepezil Sales, by Type K Units (2022-2027)
  • Table 315. Rest of South America Donepezil Sales, by Application K Units (2022-2027)
  • Table 316. Rest of South America Donepezil Sales, by Distribution Channel K Units (2022-2027)
  • Table 317. Asia Pacific Donepezil Sales, by Country K Units (2022-2027)
  • Table 318. Asia Pacific Donepezil Sales, by Type K Units (2022-2027)
  • Table 319. Asia Pacific Donepezil Sales, by Application K Units (2022-2027)
  • Table 320. Asia Pacific Donepezil Sales, by Distribution Channel K Units (2022-2027)
  • Table 321. China Donepezil Sales, by Type K Units (2022-2027)
  • Table 322. China Donepezil Sales, by Application K Units (2022-2027)
  • Table 323. China Donepezil Sales, by Distribution Channel K Units (2022-2027)
  • Table 324. Japan Donepezil Sales, by Type K Units (2022-2027)
  • Table 325. Japan Donepezil Sales, by Application K Units (2022-2027)
  • Table 326. Japan Donepezil Sales, by Distribution Channel K Units (2022-2027)
  • Table 327. India Donepezil Sales, by Type K Units (2022-2027)
  • Table 328. India Donepezil Sales, by Application K Units (2022-2027)
  • Table 329. India Donepezil Sales, by Distribution Channel K Units (2022-2027)
  • Table 330. South Korea Donepezil Sales, by Type K Units (2022-2027)
  • Table 331. South Korea Donepezil Sales, by Application K Units (2022-2027)
  • Table 332. South Korea Donepezil Sales, by Distribution Channel K Units (2022-2027)
  • Table 333. Taiwan Donepezil Sales, by Type K Units (2022-2027)
  • Table 334. Taiwan Donepezil Sales, by Application K Units (2022-2027)
  • Table 335. Taiwan Donepezil Sales, by Distribution Channel K Units (2022-2027)
  • Table 336. Australia Donepezil Sales, by Type K Units (2022-2027)
  • Table 337. Australia Donepezil Sales, by Application K Units (2022-2027)
  • Table 338. Australia Donepezil Sales, by Distribution Channel K Units (2022-2027)
  • Table 339. Rest of Asia-Pacific Donepezil Sales, by Type K Units (2022-2027)
  • Table 340. Rest of Asia-Pacific Donepezil Sales, by Application K Units (2022-2027)
  • Table 341. Rest of Asia-Pacific Donepezil Sales, by Distribution Channel K Units (2022-2027)
  • Table 342. Europe Donepezil Sales, by Country K Units (2022-2027)
  • Table 343. Europe Donepezil Sales, by Type K Units (2022-2027)
  • Table 344. Europe Donepezil Sales, by Application K Units (2022-2027)
  • Table 345. Europe Donepezil Sales, by Distribution Channel K Units (2022-2027)
  • Table 346. Germany Donepezil Sales, by Type K Units (2022-2027)
  • Table 347. Germany Donepezil Sales, by Application K Units (2022-2027)
  • Table 348. Germany Donepezil Sales, by Distribution Channel K Units (2022-2027)
  • Table 349. France Donepezil Sales, by Type K Units (2022-2027)
  • Table 350. France Donepezil Sales, by Application K Units (2022-2027)
  • Table 351. France Donepezil Sales, by Distribution Channel K Units (2022-2027)
  • Table 352. Italy Donepezil Sales, by Type K Units (2022-2027)
  • Table 353. Italy Donepezil Sales, by Application K Units (2022-2027)
  • Table 354. Italy Donepezil Sales, by Distribution Channel K Units (2022-2027)
  • Table 355. United Kingdom Donepezil Sales, by Type K Units (2022-2027)
  • Table 356. United Kingdom Donepezil Sales, by Application K Units (2022-2027)
  • Table 357. United Kingdom Donepezil Sales, by Distribution Channel K Units (2022-2027)
  • Table 358. Netherlands Donepezil Sales, by Type K Units (2022-2027)
  • Table 359. Netherlands Donepezil Sales, by Application K Units (2022-2027)
  • Table 360. Netherlands Donepezil Sales, by Distribution Channel K Units (2022-2027)
  • Table 361. Rest of Europe Donepezil Sales, by Type K Units (2022-2027)
  • Table 362. Rest of Europe Donepezil Sales, by Application K Units (2022-2027)
  • Table 363. Rest of Europe Donepezil Sales, by Distribution Channel K Units (2022-2027)
  • Table 364. MEA Donepezil Sales, by Country K Units (2022-2027)
  • Table 365. MEA Donepezil Sales, by Type K Units (2022-2027)
  • Table 366. MEA Donepezil Sales, by Application K Units (2022-2027)
  • Table 367. MEA Donepezil Sales, by Distribution Channel K Units (2022-2027)
  • Table 368. Middle East Donepezil Sales, by Type K Units (2022-2027)
  • Table 369. Middle East Donepezil Sales, by Application K Units (2022-2027)
  • Table 370. Middle East Donepezil Sales, by Distribution Channel K Units (2022-2027)
  • Table 371. Africa Donepezil Sales, by Type K Units (2022-2027)
  • Table 372. Africa Donepezil Sales, by Application K Units (2022-2027)
  • Table 373. Africa Donepezil Sales, by Distribution Channel K Units (2022-2027)
  • Table 374. North America Donepezil Sales, by Country K Units (2022-2027)
  • Table 375. North America Donepezil Sales, by Type K Units (2022-2027)
  • Table 376. North America Donepezil Sales, by Application K Units (2022-2027)
  • Table 377. North America Donepezil Sales, by Distribution Channel K Units (2022-2027)
  • Table 378. United States Donepezil Sales, by Type K Units (2022-2027)
  • Table 379. United States Donepezil Sales, by Application K Units (2022-2027)
  • Table 380. United States Donepezil Sales, by Distribution Channel K Units (2022-2027)
  • Table 381. Canada Donepezil Sales, by Type K Units (2022-2027)
  • Table 382. Canada Donepezil Sales, by Application K Units (2022-2027)
  • Table 383. Canada Donepezil Sales, by Distribution Channel K Units (2022-2027)
  • Table 384. Mexico Donepezil Sales, by Type K Units (2022-2027)
  • Table 385. Mexico Donepezil Sales, by Application K Units (2022-2027)
  • Table 386. Mexico Donepezil Sales, by Distribution Channel K Units (2022-2027)
  • Table 387. Donepezil: by Type(USD/Units)
  • Table 388. Research Programs/Design for This Report
  • Table 389. Key Data Information from Secondary Sources
  • Table 390. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Donepezil: by Type USD Million (2016-2021)
  • Figure 5. Global Donepezil: by Application USD Million (2016-2021)
  • Figure 6. Global Donepezil: by Distribution Channel USD Million (2016-2021)
  • Figure 7. South America Donepezil Share (%), by Country
  • Figure 8. Asia Pacific Donepezil Share (%), by Country
  • Figure 9. Europe Donepezil Share (%), by Country
  • Figure 10. MEA Donepezil Share (%), by Country
  • Figure 11. North America Donepezil Share (%), by Country
  • Figure 12. Global Donepezil: by Type K Units (2016-2021)
  • Figure 13. Global Donepezil: by Application K Units (2016-2021)
  • Figure 14. Global Donepezil: by Distribution Channel K Units (2016-2021)
  • Figure 15. South America Donepezil Share (%), by Country
  • Figure 16. Asia Pacific Donepezil Share (%), by Country
  • Figure 17. Europe Donepezil Share (%), by Country
  • Figure 18. MEA Donepezil Share (%), by Country
  • Figure 19. North America Donepezil Share (%), by Country
  • Figure 20. Global Donepezil: by Type USD/Units (2016-2021)
  • Figure 21. Global Donepezil share by Players 2021 (%)
  • Figure 22. Global Donepezil share by Players (Top 3) 2021(%)
  • Figure 23. Global Donepezil share by Players (Top 5) 2021(%)
  • Figure 24. BCG Matrix for key Companies
  • Figure 25. Eisai (Japan) Revenue, Net Income and Gross profit
  • Figure 26. Eisai (Japan) Revenue: by Geography 2021
  • Figure 27. Pfizer (United States) Revenue, Net Income and Gross profit
  • Figure 28. Pfizer (United States) Revenue: by Geography 2021
  • Figure 29. Teva (Israel) Revenue, Net Income and Gross profit
  • Figure 30. Teva (Israel) Revenue: by Geography 2021
  • Figure 31. Sandoz (Germany) Revenue, Net Income and Gross profit
  • Figure 32. Sandoz (Germany) Revenue: by Geography 2021
  • Figure 33. Apotex (Canada) Revenue, Net Income and Gross profit
  • Figure 34. Apotex (Canada) Revenue: by Geography 2021
  • Figure 35. Dr Reddy's Laboratories (India) Revenue, Net Income and Gross profit
  • Figure 36. Dr Reddy's Laboratories (India) Revenue: by Geography 2021
  • Figure 37. Sun Pharmaceutical (India) Revenue, Net Income and Gross profit
  • Figure 38. Sun Pharmaceutical (India) Revenue: by Geography 2021
  • Figure 39. Hansoh Pharma (China) Revenue, Net Income and Gross profit
  • Figure 40. Hansoh Pharma (China) Revenue: by Geography 2021
  • Figure 41. Cipla (India) Revenue, Net Income and Gross profit
  • Figure 42. Cipla (India) Revenue: by Geography 2021
  • Figure 43. Global Donepezil: by Type USD Million (2022-2027)
  • Figure 44. Global Donepezil: by Application USD Million (2022-2027)
  • Figure 45. Global Donepezil: by Distribution Channel USD Million (2022-2027)
  • Figure 46. South America Donepezil Share (%), by Country
  • Figure 47. Asia Pacific Donepezil Share (%), by Country
  • Figure 48. Europe Donepezil Share (%), by Country
  • Figure 49. MEA Donepezil Share (%), by Country
  • Figure 50. North America Donepezil Share (%), by Country
  • Figure 51. Global Donepezil: by Type K Units (2022-2027)
  • Figure 52. Global Donepezil: by Application K Units (2022-2027)
  • Figure 53. Global Donepezil: by Distribution Channel K Units (2022-2027)
  • Figure 54. South America Donepezil Share (%), by Country
  • Figure 55. Asia Pacific Donepezil Share (%), by Country
  • Figure 56. Europe Donepezil Share (%), by Country
  • Figure 57. MEA Donepezil Share (%), by Country
  • Figure 58. North America Donepezil Share (%), by Country
  • Figure 59. Global Donepezil: by Type USD/Units (2022-2027)
List of companies from research coverage that are profiled in the study
  • Eisai (Japan)
  • Pfizer (United States)
  • Teva (Israel)
  • Sandoz (Germany)
  • Apotex (Canada)
  • Dr Reddy's Laboratories (India)
  • Sun Pharmaceutical (India)
  • Hansoh Pharma (China)
  • Cipla (India)
Additional players considered in the study are as follows:
Shandong Luoxin Pharmaceutical Group (China) , Sichuan Jishengtang Pharmaceutical Co Ltd (China)
Select User Access Type

Key Highlights of Report


Mar 2022 239 Pages 71 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Donepezil Market Quantitative research analysis
Global Donepezil Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Historical year: 2017-2021; Base year: 2021; Forecast period: 2022 to 2027
Companies that are profiled in Global Donepezil Market are Eisai (Japan), Pfizer (United States), Teva (Israel), Sandoz (Germany), Apotex (Canada), Dr Reddy's Laboratories (India), Sun Pharmaceutical (India), Hansoh Pharma (China) and Cipla (India) etc.
Donepezil is also called as Aricept. Donepezil is a medication that used to treatment of Alzheimer's disease. It is available in 5mg, 10mg and 23mg. Donepezil was approved for medical use in the United States in 1996. It is available online as well as offline. Rising prevalence of Alzheimer’s disease and increasing geriatric population worldwide will help to boost the global Donepezil market.

Know More About Global Donepezil Market Report?

Have a Query? Click Here

Other Related Reports

Leukemia Therapeutics Comprehensive Study by Type (Chemotherapy, Biological Therapy, Radiation therapy, Targeted therapy), Application (Hospital, Clinic), Mode of Administration (Oral, Injectable), M...
$ 3750
Age Related Macular Degeneration Comprehensive Study by Type (Wet AMD, Dry AMD), Drugs (Lucentis, Eylea, Avastin, Others), Route of Administration (Intravenous, Intravitreal) Players and Region - Glo...
$ 3500
Diabetic Nephropathy Comprehensive Study by Application (Hospitals, Cancer Research Institutes, Diagnostic Labs), Treatment (Medication, Kidney Dialysis, Kidney Transplant), Stages (Microalbuminuria ...
$ 3750
Negative Pressure Wound Therapy Comprehensive Study by Type (Standalone NPWT Devices, Single use Disposable NPWT Devices, Portable NPWT Devices, NPWT Accessories (Canister)), Application (Hospital, C...
$ 3350
Chitosan Gel Comprehensive Study by Type (Industrial Grade, Pharmaceutical Grade, Others), Application (Surgical, Gynecological Diseases, Hemorrhoid Disease, Others), Distribution Channel (Hospital P...
$ 3450
Rosacea Treatment Comprehensive Study by Type (Erythematotelangiectatic Rosacea, Papulopustular Rosacea, Ocular Rosacea, Phymatous Rosacea), Drugs (Rhofade, Mirvaso, Oracea, Others), Route of Adminis...
$ 3750